Phase 1 Urticaria Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults
Chronic Spontaneous UrticariaChronic Inducible Urticaria
Enanta Pharmaceuticals, Inc98 enrolled1 locationNCT07540910
Recruiting
Phase 1
A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
Healthy SubjectsChronic Inducible UrticariaCold Urticaria+1 more
Granular Therapeutics Limited72 enrolled2 locationsNCT07181369
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes
Chronic Spontaneous Urticaria
Chengdu Suncadia Medicine Co., Ltd.66 enrolled1 locationNCT07230418
Completed
Phase 1
A Phase I randomized blinded single dose comparison of the safety pharmacokinetics and pharmacodynamics of SYN008 and omalizumab (Xolair) in healthy adult subjects
Moderate to severe persistent asthmaChronic idiopathic urticaria
Clinical Network Services (CNS) Pty Ltd80 enrolled1 locationACTRN12616000145404